VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹264 Cr | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹264 Cr |
| Mar2024 | ₹267 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹301 Cr |
| Mar2021 | ₹322 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹264 Cr | -1.23 | |
| Mar2024 | ₹267 Cr | -3.93 | |
| Mar2023 | ₹278 Cr | -7.59 | |
| Mar2022 | ₹301 Cr | -6.44 | |
| Mar2021 | ₹322 Cr | - | |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹960.5 Cr | 29% | 59.2% | 138.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 29% |
59.2% |
138.6% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses